Literature DB >> 5655100

Induction of bone marrow colony-stimulating activity by a filterable agent in leukemic and normal mouse serum.

R Foster, D Metcalf, R Kirchmyer.   

Abstract

1. Leukemic Swiss mice of ICR/Ha strain which had been injected at birth with a lymphoid-leukemia-inducing virus preparation yielded sera which produced elevations of serum colony-stimulating activity within 16 hr and significant plasma-LDH-enzyme elevation at 4 days when injected intraperitoneally into normal ICR/Ha Swiss mice. Colony-stimulating activity was assayed in vitro by the stimulation of hemopoietic colony formation by DBA/1 bone marrow cells. 2. The inducing agent in leukemic serum was passageable, filterable, sedimentable, and heat-, ether-, and UV-labile. 3. A similar agent was recovered from normal Swiss serum after blind serial passages through normal mice. 4. LDH elevating virus induced a similar elevation of serum colony-stimulating activity when injected at high titers, and cross-resistance was demonstrated between LDH virus and the passaged leukemic serum agent.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5655100      PMCID: PMC2138494          DOI: 10.1084/jem.127.5.853

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  8 in total

1.  PROPERTIES OF A LYMPHOCYTIC LEUKEMIA AGENT ISOLATED FROM HA/ICR SWISS MICE.

Authors:  R F BUFFETT; J T GRACE; E A MIRAND
Journal:  Proc Soc Exp Biol Med       Date:  1964-06

2.  GROWTH CURVE OF A MURINE LEUKEMIA VIRUS IN MICE.

Authors:  F J RAUSCHER; B V ALLEN
Journal:  J Natl Cancer Inst       Date:  1964-02       Impact factor: 13.506

3.  Enzymatic determination of transmissible replicating factors associated with mouse tumors.

Authors:  V RILEY
Journal:  Ann N Y Acad Sci       Date:  1963-02-15       Impact factor: 5.691

4.  Rapid intracerebral passage and recovery of Moloney leukemia virus from mouse brain tissue.

Authors:  H J SPENCER
Journal:  J Natl Cancer Inst       Date:  1963-02       Impact factor: 13.506

5.  Bone marrow colony-stimulating activity of serum from mice with viral-induced leukemia.

Authors:  D Metcalf; R Foster
Journal:  J Natl Cancer Inst       Date:  1967-12       Impact factor: 13.506

6.  Riley virus neutralizing activity in the plasma of infected mice with persistent viraemia.

Authors:  K E Rowson; B W Mahy; M Bendinelli
Journal:  Virology       Date:  1966-04       Impact factor: 3.616

7.  Colony stimulating activity of serum from germfree normal and leukemic mice.

Authors:  D Metcalf; R Foster; M Pollard
Journal:  J Cell Physiol       Date:  1967-08       Impact factor: 6.384

8.  Transmissible Agent Associated with 26 Types of Experimental Mouse Neoplasms.

Authors:  V Riley; F Lilly; E Huerto; D Bardell
Journal:  Science       Date:  1960-08-26       Impact factor: 47.728

  8 in total
  6 in total

1.  Granulocyte-macrophage colony-stimulating activity in the serum of mice stimulated with homogenates of Trypanosoma gambiense.

Authors:  M Oka; H Nagasawa; Y Ito; K Himeno
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

2.  Acute antigen-induced elevation of serum colony stimulating factor (CFS) levels.

Authors:  D Metcalf
Journal:  Immunology       Date:  1971-09       Impact factor: 7.397

3.  Production of colony-stimulating factor in mixed leucocyte cultures.

Authors:  J W Parker; D Metcalf
Journal:  Immunology       Date:  1974-05       Impact factor: 7.397

Review 4.  Diagnostic and prognostic value of colony formation of hematopoietic progenitor cells in myeloid malignancies.

Authors:  Leopold Ohler; Klaus Geissler; Wolfgang Hinterberger
Journal:  Wien Klin Wochenschr       Date:  2003-08-14       Impact factor: 1.704

5.  Granulocyte-macrophage colony-stimulating factor in the sera of Schistosoma japonicum-infected mice.

Authors:  M Owhashi; Y Nawa
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

Review 6.  Human leukaemia: recent tissue culture studies on the nature of myeloid leukaemia.

Authors:  D Metcalf
Journal:  Br J Cancer       Date:  1973-03       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.